MedTrace Logo

Comparing Analgesic Effects of Wound Infiltration Using Bupivacaine, Tramadol, and Tramadol Plus Bupivacaine

NCT06076707 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2023-11-07

No results posted yet for this study

Summary

The goal of this study's clinical trial is to compare in post-operative analgesic effectiveness of wound infiltration using bupivacaine, tramadol, and tramadol plus bupivacaine in patients undergoing elective cesarean section under spinal anesthesia. The main question the study aimed to answer is "which approach is best among the 3"

all participants need to respond to the pain severity for the data collectors and they will receive treatments accordingly There will be 3 groups in the study

* group T: for tramadol
* group B: for bupivacaine
* group TB : tramadol + bupivacaine

Conditions

  • Pain, Postoperative

Interventions

DRUG

bupivacain-tramadol

Comparing effectiveness of tramadol and bupivacaine for postoperative pain treatment and prevention for cesarian section

Sponsors & Collaborators

  • Wollo University

    lead OTHER

Principal Investigators

  • Woldemichael · Wollo Universty

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2024-05-30
Completion
2024-06-02

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06076707 on ClinicalTrials.gov